Atlas Trials

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

Clinical trial NCT02113163 · COMPLETED

Trial details

NCT number
NCT02113163
Sponsor
Thetis Pharmaceuticals LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Non-Insulin-DependentHypertriglyceridemia
Start date
2014-03-01
Primary completion
2014-06-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.